A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

BACKGROUND: Isoniazid (INH, H) resistance is the most common drug-resistant TB pattern, with treatment success rates lower than those in drug-susceptible TB. The WHO recommends a 6-month regimen of rifampicin (RIF, R), ethambutol (EMB, E), pyrazinamide (PZA, Z), and levofloxacin (Lfx) (6REZLfx) for...

Full description

Saved in:
Bibliographic Details
Main Authors: M.L. Rekart, P. Thit, M. Oluya, S. Moe, T. Hasan, N. Parpieva, K. Safaev, A. Khristusev, T. Zinaida, J. Singh, S. Allamuratova, I. Azamat, C.G. Restrepo, N. Sitali, J. Achar, J.L. Alvaraez, A. Sinha
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-07-01
Series:IJTLD Open
Subjects:
inh resistance
central asia
6rezlfx
drug-resistant tb
dr-tb
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000007/art00002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items